Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Receivables (2019 - 2025)

Outset Medical (OM) has disclosed Receivables for 7 consecutive years, with $28.3 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 20.47% to $28.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.3 million through Dec 2025, down 20.47% year-over-year, with the annual reading at $28.3 million for FY2025, 20.47% down from the prior year.
  • Receivables for Q4 2025 was $28.3 million at Outset Medical, down from $33.0 million in the prior quarter.
  • The five-year high for Receivables was $36.9 million in Q2 2023, with the low at $12.1 million in Q1 2021.
  • Average Receivables over 5 years is $29.4 million, with a median of $33.0 million recorded in 2023.
  • The sharpest move saw Receivables skyrocketed 295.79% in 2021, then dropped 20.47% in 2025.
  • Over 5 years, Receivables stood at $25.6 million in 2021, then increased by 9.65% to $28.1 million in 2022, then grew by 17.49% to $33.0 million in 2023, then rose by 8.0% to $35.6 million in 2024, then fell by 20.47% to $28.3 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $28.3 million, $33.0 million, and $34.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.